Trials / Conditions / Lung Adenocarcinoma Stage IV
Lung Adenocarcinoma Stage IV
3 registered clinical trials studyying Lung Adenocarcinoma Stage IV — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | SBU-RESET: RElaxation, Stress Reduction and Epigenetics Trial in Cancer Survivors NCT07161713 | Barbara Nemesure | N/A |
| Recruiting | Neoadjuvant Furmonertinib Plus Bevacizumab or Furmonertinib Monotherapy for Resectable and Potentially Resecta NCT05503667 | Shanghai Pulmonary Hospital, Shanghai, China | Phase 2 |
| Completed | Efficacy and Safety of Tislelizumab Combined With Bevacizumab and Albumin Paclitaxel in Lung Adenocarcinoma NCT04310943 | Zhou Chengzhi | Phase 2 |